HCA Healthcare Rg
HCA
USD
STOCK MARKET:
NYX
Closed
 
...
Price in deferred time of 15 minutes
Last quote
05/24/2024 - 16:15:00
Bid
05/24/2024 - 15:59:59
Bid
Volume
Ask
05/24/2024 - 15:59:59
Ask
Volume
318.70
+3.38 ( +1.07% )
318.67
2,100
318.70
4,800
More information
Analysis by TheScreener
24.05.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 24.05.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 01.03.2024.
Interest
  Strong
Strong interest since 21.05.2024.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 21.05.2024 at a price of 321.12.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 10.05.2024), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 312.681.
4wk Rel Perf
  -4.70%
 
The four week relative underperformance versus SP500 is 4.70%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 10.10.2023.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.08%.
Mkt Cap in $bn
  82.59
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
  0.99
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  12.39
The estimated PE is for the year 2026.
LT Growth
  11.35%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
  0.85%
The twelve month estimated dividend yield represents 10.57% of earnings forecasts.
Beta
  82
For 1% of index variation, the stock varies on average by 0.82%.
Correlation
  0.47
46.59% of stock movements are explained by index variations.
Value at Risk
  38.28
The value at risk is estimated at USD 38.28. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  27.07.2011